Rule Amends Blood Test Requirement for Newborns
[from the Maine Hospital Association's EClips]
The Maine Center for Disease Control and Prevention has adopted
new requirements
for its newborn screening program.
The revised rule, which was released and took effect November
14, amends the requirements for healthcare providers to test for certain
congenital genetic disorders, which, if left untreated, can cause intellectual
and developmental disability, serious illness or death.
The rule also amends the protocols for collecting and storing
newborn bloodspot screening (NBS) specimens and for reporting out-of-range
results. It also establishes conditions
for releasing NBS samples for research purposes and specifies that
parents/legal guardians may request that their child’s residual filter paper
specimens be destroyed.
< Previous Article |
Next Article >
[ return to top ]
|
In This Issue
